We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Aspirin Use, Lipoprotein(a), and Calcific Aortic Valve Disease: Insights from the Multi-Ethnic Study of Atherosclerosis

MedXY Editorial Team•Sep 11, 2026•Cardiology
Lipoprotein(a)calcific aortic valve diseaseAspirinaortic stenosis

Highlights

  • Elevated lipoprotein(a) (Lp(a)) is a strong causal factor for aortic valve calcium (AVC) and aortic stenosis (AS).

  • Aspirin use was associated with a significantly lower risk of incident AVC and severe AS among persons with high Lp(a), but no benefit was observed in those with elevated LDL cholesterol (LDL-C).

  • This suggests aspirin’s antithrombotic and anti-fibrinolytic properties may mitigate valve calcification processes specifically linked to Lp(a)-mediated disease pathways.

  • Further confirmatory, ideally randomized, studies are needed to validate aspirin as a preventive strategy for calcific aortic valve disease in high Lp(a) populations.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Ticagrelor-Aspirin Dual Therapy After Thrombolysis in Moderate Ischemic Stroke: Insights from Infarct Patterns in the TAPIS TrialTAPIS subgroup analysis reveals that ticagrelor-aspirin combined with thrombolysis may improve outcomes in moderate ischemic stroke patients with multiple acute infarcts, without increasing hemorrhage risk, suggesting infarct pattern as a pSep 6, 2026Lepodisiran’s Impact on Oxidized Phospholipids in Lipoprotein(a): Advancing Cardiovascular Risk ReductionLepodisiran, an siRNA targeting Lp(a), significantly reduces oxidized phospholipids on apo(a) and apoB, highlighting its therapeutic potential in lowering cardiovascular risk linked to elevated Lp(a).Sep 6, 2026Evaluating Tirofiban Plus Aspirin in Branch Atheromatous Disease Stroke: Insights from the STRATEGY TrialThe STRATEGY trial assessed whether combining tirofiban with aspirin improves outcomes in branch atheromatous disease (BAD)-related stroke but found no significant benefit over aspirin alone in preventing neurological deterioration or recurSep 5, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Risk Across the Adult Lifespan: Insights from a Large Population Study
Elevated lipoprotein(a) confers a consistent relative risk increase for atherosclerotic cardiovascular disease across all adult ages, with absolute risks rising substantially in older adults.
Sep 1, 2026
Universal Aspirin Dispensation for Prevention of Preeclampsia in High-Risk Pregnancies: Evidence Synthesis and Clinical ImplicationsUniversal dispensation of aspirin at 162 mg daily in high-risk pregnant populations reduces preeclampsia with severe features without increasing adverse maternal or neonatal outcomes, supporting broad aspirin use beyond risk-based prescribiAug 31, 2026
Revolutionizing Aortic Stenosis Screening: AI-Enabled Focused Cardiac Ultrasound with Novice OperatorsA novel deep learning algorithm accurately detects moderate or greater aortic stenosis using AI-guided focused cardiac ultrasound acquired by novice operators, presenting a scalable solution to expand screening accessibility.Aug 29, 2026